- Home
- EHC
as 07-26-2024 4:00pm EST
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
| Founded: | 1983 | Country: | United States |
| Employees: | N/A | City: | BIRMINGHAM |
| Market Cap: | 8.7B | IPO Year: | 1986 |
| Target Price: | $93.56 | AVG Volume (30 days): | 625.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 9 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 3.69 | EPS Growth: | 36.67 |
| 52 Week Low/High: | $57.55 - $91.96 | Next Earning Date: | 08-05-2024 |
| Revenue: | $4,956,800,000 | Revenue Growth: | 11.40% |
| Revenue Growth (this year): | 11.7% | Revenue Growth (next year): | 8.99% |
Stock Insider Trading Activity of Encompass Health Corporation (EHC)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Darby John Patrick | EHC | EVP, Gen Counsel & Secretary | May 6 '24 | Sell | $83.94 | 14,543 | $1,220,739.42 | 84,773 | SEC Form 4 |
| CARMICHAEL GREG D | EHC | Director | May 3 '24 | Buy | $83.73 | 2,000 | $167,460.00 | 17,050 | SEC Form 4 |
| Tarr Mark J | EHC | President & CEO | Apr 30 '24 | Sell | $83.27 | 44,976 | $3,745,151.52 | 554,098 | SEC Form 4 |
| COLTHARP DOUGLAS E | EHC | EVP & Chief Financial Officer | Nov 13 '23 | Sell | $63.39 | 11,215 | $710,918.85 | 116,293 | SEC Form 4 |
Latest Encompass Health Corporation News
EHC Breaking Stock News: Dive into EHC Ticker-Specific Updates for Smart Investing
MT Newswires
2 days ago
Encompass Health Raises Dividend, Boosts Share Repurchase Authorization
PR Newswire
3 days ago
Encompass Health increases and declares dividend on common stock and announces increase in common stock repurchase authorization
Argus Research
3 days ago
EHC: What does Argus have to say about EHC?
Zacks
3 days ago
HCA Healthcare (HCA) Beats on Q2 Earnings, Ups 2024 EPS View
Argus Research
10 days ago
EHC: Raising target price to $91.00
Zacks
10 days ago
UnitedHealth Group (UNH) Q2 Earnings Beat on Strong Optum Unit
MT Newswires
11 days ago
Truist Securities Adjusts Price Target on Encompass Health to $100 From $95, Maintains Buy Rating
PR Newswire
11 days ago
Encompass Health issues notice for partial redemption of its 5.75% senior notes due 2025
Compare EHC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EHC Encompass Health Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.